Sanofi Scraps $755M Licensing Deal Amid FTC Challenge
By Matthew Perlman ( December 11, 2023, 10:07 PM EST) -- Sanofi said Monday it will terminate a planned licensing agreement with Maze Therapeutics after the Federal Trade Commission moved to block the $755 million deal over concerns about a potential competitor to Sanofi's Pompe disease treatments....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.